389 related articles for article (PubMed ID: 16927363)
1. Characterisation of a P140K mutant O6-methylguanine-DNA-methyltransferase (MGMT)-expressing transgenic mouse line with drug-selectable bone marrow.
Kramer BA; Lemckert FA; Alexander IE; Gunning PW; McCowage GB
J Gene Med; 2006 Sep; 8(9):1071-85. PubMed ID: 16927363
[TBL] [Abstract][Full Text] [Related]
2. Hematoprotection and enrichment of transduced cells in vivo after gene transfer of MGMT(P140K) into hematopoietic stem cells.
Jansen M; Sorg UR; Ragg S; Flasshove M; Seeber S; Williams DA; Moritz T
Cancer Gene Ther; 2002 Sep; 9(9):737-46. PubMed ID: 12189523
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow-derived cells exhibiting lung epithelial cell characteristics are enriched in vivo using methylguanine DNA methyltransferase-mediated drug resistance.
Reese JS; Roth JC; Gerson SL
Stem Cells; 2008 Mar; 26(3):675-81. PubMed ID: 18192231
[TBL] [Abstract][Full Text] [Related]
4. Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo.
Moritz T; Mackay W; Glassner BJ; Williams DA; Samson L
Cancer Res; 1995 Jun; 55(12):2608-14. PubMed ID: 7780976
[TBL] [Abstract][Full Text] [Related]
5. Reversal of 1,3-bis(2-chloroethyl)-1-nitrosourea-induced severe immunodeficiency by transduction of murine long-lived hemopoietic progenitor cells using O6-methylguanine DNA methyltransferase complementary DNA.
Maze R; Kapur R; Kelley MR; Hansen WK; Oh SY; Williams DA
J Immunol; 1997 Jan; 158(2):1006-13. PubMed ID: 8993023
[TBL] [Abstract][Full Text] [Related]
6. Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells.
Ragg S; Xu-Welliver M; Bailey J; D'Souza M; Cooper R; Chandra S; Seshadri R; Pegg AE; Williams DA
Cancer Res; 2000 Sep; 60(18):5187-95. PubMed ID: 11016647
[TBL] [Abstract][Full Text] [Related]
7. A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell lines.
Richard E; Géronimi F; Lalanne M; Ged C; Redonnet-Vernhet I; Lamrissi-Garcia I; Gerson SL; de Verneuil H; Moreau-Gaudry F
J Gene Med; 2003 Sep; 5(9):737-47. PubMed ID: 12950064
[TBL] [Abstract][Full Text] [Related]
8. Human alkyltransferase-transduced murine myeloid progenitors are enriched in vivo by BCNU treatment of transplanted mice.
Allay JA; Davis BM; Gerson SL
Exp Hematol; 1997 Sep; 25(10):1069-76. PubMed ID: 9293904
[TBL] [Abstract][Full Text] [Related]
9. O6-methylguanine-DNA-methyltransferase (MGMT) gene therapy targeting haematopoietic stem cells: studies addressing safety issues.
Sorg UR; Kleff V; Fanaei S; Schumann A; Moellmann M; Opalka B; Thomale J; Moritz T
DNA Repair (Amst); 2007 Aug; 6(8):1197-209. PubMed ID: 17499560
[TBL] [Abstract][Full Text] [Related]
10. Selection for G156A O6-methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and protection from lethality in mice treated with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Davis BM; Reese JS; Koç ON; Lee K; Schupp JE; Gerson SL
Cancer Res; 1997 Nov; 57(22):5093-9. PubMed ID: 9371508
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic expression of O(6)-methylguanine DNA methyltransferase-P140K allows intensive treatment of human glioma xenografts with combination O(6)-benzylguanine and 1,3-bis-(2-chloroethyl)-1-nitrosourea.
Kreklau EL; Pollok KE; Bailey BJ; Liu N; Hartwell JR; Williams DA; Erickson LC
Mol Cancer Ther; 2003 Dec; 2(12):1321-9. PubMed ID: 14707273
[TBL] [Abstract][Full Text] [Related]
12. In vivo selection of MGMT(P140K) lentivirus-transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioning.
Zielske SP; Reese JS; Lingas KT; Donze JR; Gerson SL
J Clin Invest; 2003 Nov; 112(10):1561-70. PubMed ID: 14617757
[TBL] [Abstract][Full Text] [Related]
13. Stable differentiation and clonality of murine long-term hematopoiesis after extended reduced-intensity selection for MGMT P140K transgene expression.
Ball CR; Pilz IH; Schmidt M; Fessler S; Williams DA; von Kalle C; Glimm H
Blood; 2007 Sep; 110(6):1779-87. PubMed ID: 17496202
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the P140K, PVP(138-140)MLK, and G156A O6-methylguanine-DNA methyltransferase mutants: implications for drug resistance gene therapy.
Davis BM; Roth JC; Liu L; Xu-Welliver M; Pegg AE; Gerson SL
Hum Gene Ther; 1999 Nov; 10(17):2769-78. PubMed ID: 10584923
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral transduction of P140K MGMT into human CD34(+) hematopoietic progenitors at low multiplicity of infection confers significant resistance to BG/BCNU and allows selection in vitro.
Zielske SP; Gerson SL
Mol Ther; 2002 Apr; 5(4):381-7. PubMed ID: 11945064
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal relationship between O6-methylguanine-DNA methyltransferase P140K expression level and chemoprotection of hematopoietic stem cells.
Milsom MD; Jerabek-Willemsen M; Harris CE; Schambach A; Broun E; Bailey J; Jansen M; Schleimer D; Nattamai K; Wilhelm J; Watson A; Geiger H; Margison GP; Moritz T; Baum C; Thomale J; Williams DA
Cancer Res; 2008 Aug; 68(15):6171-80. PubMed ID: 18676840
[TBL] [Abstract][Full Text] [Related]
17. Vector design for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.
Schambach A; Baum C
DNA Repair (Amst); 2007 Aug; 6(8):1187-96. PubMed ID: 17482894
[TBL] [Abstract][Full Text] [Related]
18. In vivo effects of myeloablative alkylator therapy on survival and differentiation of MGMTP140K-transduced human G-CSF-mobilized peripheral blood cells.
Cai S; Hartwell JR; Cooper RJ; Juliar BE; Kreklau E; Abonour R; Goebel WS; Pollok KE
Mol Ther; 2006 May; 13(5):1016-26. PubMed ID: 16426896
[TBL] [Abstract][Full Text] [Related]
19. Towards hematopoietic stem cell-mediated protection against infection with human immunodeficiency virus.
Schambach A; Schiedlmeier B; Kühlcke K; Verstegen M; Margison GP; Li Z; Kamino K; Bohne J; Alexandrov A; Hermann FG; von Laer D; Baum C
Gene Ther; 2006 Jul; 13(13):1037-47. PubMed ID: 16541120
[TBL] [Abstract][Full Text] [Related]
20. Differential competitive resistance to methylating versus chloroethylating agents among five O6-alkylguanine DNA alkyltransferases in human hematopoietic cells.
Fontes AM; Davis BM; Encell LP; Lingas K; Covas DT; Zago MA; Loeb LA; Pegg AE; Gerson SL
Mol Cancer Ther; 2006 Jan; 5(1):121-8. PubMed ID: 16432170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
